RIVOLTA, ILARIA
 Distribuzione geografica
Continente #
NA - Nord America 13.059
EU - Europa 6.727
AS - Asia 6.649
SA - Sud America 1.024
AF - Africa 172
Continente sconosciuto - Info sul continente non disponibili 18
OC - Oceania 14
Totale 27.663
Nazione #
US - Stati Uniti d'America 12.709
SG - Singapore 2.332
IT - Italia 1.666
CN - Cina 1.500
DE - Germania 1.193
VN - Vietnam 911
HK - Hong Kong 881
RU - Federazione Russa 830
BR - Brasile 798
SE - Svezia 615
IE - Irlanda 531
GB - Regno Unito 388
UA - Ucraina 359
CA - Canada 255
FR - Francia 248
IN - India 234
FI - Finlandia 229
AT - Austria 157
DK - Danimarca 103
BD - Bangladesh 101
ID - Indonesia 93
TR - Turchia 85
ES - Italia 80
KR - Corea 77
IQ - Iraq 76
AR - Argentina 73
NL - Olanda 69
PL - Polonia 66
ZA - Sudafrica 64
MX - Messico 63
PK - Pakistan 58
JP - Giappone 52
BE - Belgio 50
EC - Ecuador 40
SA - Arabia Saudita 40
PH - Filippine 32
CH - Svizzera 30
CO - Colombia 26
VE - Venezuela 25
CL - Cile 22
UZ - Uzbekistan 22
MA - Marocco 19
PY - Paraguay 19
RO - Romania 19
AE - Emirati Arabi Uniti 17
HU - Ungheria 17
IR - Iran 17
JO - Giordania 16
BG - Bulgaria 15
KE - Kenya 15
EG - Egitto 14
EU - Europa 14
MY - Malesia 14
LT - Lituania 13
AZ - Azerbaigian 11
NP - Nepal 11
AU - Australia 10
DZ - Algeria 10
ET - Etiopia 10
TN - Tunisia 10
AL - Albania 9
PT - Portogallo 8
UY - Uruguay 8
IL - Israele 7
BO - Bolivia 6
BY - Bielorussia 6
CZ - Repubblica Ceca 6
GE - Georgia 6
KZ - Kazakistan 6
PS - Palestinian Territory 6
RS - Serbia 6
SN - Senegal 6
TH - Thailandia 6
CX - Isole del Natale 5
HN - Honduras 5
LB - Libano 5
NG - Nigeria 5
OM - Oman 5
PE - Perù 5
DO - Repubblica Dominicana 4
JM - Giamaica 4
KG - Kirghizistan 4
NI - Nicaragua 4
PA - Panama 4
SC - Seychelles 4
SK - Slovacchia (Repubblica Slovacca) 4
TT - Trinidad e Tobago 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AO - Angola 3
BH - Bahrain 3
BT - Bhutan 3
GR - Grecia 3
NZ - Nuova Zelanda 3
BJ - Benin 2
KH - Cambogia 2
LY - Libia 2
NO - Norvegia 2
SV - El Salvador 2
TW - Taiwan 2
AM - Armenia 1
Totale 27.633
Città #
Ann Arbor 2.122
Singapore 1.439
Ashburn 1.127
Woodbridge 885
Hong Kong 869
Frankfurt am Main 817
Chandler 734
Fairfield 722
San Jose 662
Wilmington 526
Dublin 518
Houston 490
Milan 421
Dallas 366
Jacksonville 340
New York 321
Dearborn 310
Santa Clara 308
Ho Chi Minh City 271
Seattle 267
Beijing 219
Cambridge 214
Los Angeles 207
Princeton 198
Chicago 185
The Dalles 169
Hanoi 166
Munich 151
Nanjing 142
Vienna 142
Rome 139
Helsinki 124
Shanghai 115
Hefei 111
Lauterbourg 102
Moscow 87
Buffalo 83
São Paulo 82
Lawrence 80
Council Bluffs 77
Toronto 72
Altamura 69
Guangzhou 69
Seoul 68
Jakarta 65
Lachine 54
San Diego 49
Dong Ket 46
London 46
Orem 46
Nanchang 44
Brussels 42
Fremont 40
Ottawa 39
Montreal 38
Boardman 37
Denver 37
Andover 35
Haiphong 34
Brooklyn 33
Chennai 33
Tokyo 33
Da Nang 32
Warsaw 32
Johannesburg 31
Changsha 30
Rio de Janeiro 30
Baghdad 29
Bologna 29
Shenyang 29
Tianjin 28
Kraków 27
Pune 27
Turku 27
Atlanta 26
Bari 26
Bergamo 26
Zhengzhou 26
Falls Church 25
Lahore 25
Columbus 24
Nuremberg 24
Jinan 23
Phoenix 23
Poplar 21
Verona 21
Washington 21
Manchester 20
Norwalk 20
Stockholm 20
Tashkent 20
Hebei 19
Mumbai 19
Edmonton 18
Turin 18
Brugherio 17
Dhaka 17
Belo Horizonte 16
Biên Hòa 16
Brasília 16
Totale 18.235
Nome #
Vander Fisiologia 670
Innovative and Efficient Oral Delivery Method of APOA-1Milano Muteins Which Retain Anti-Atherosclerotic and Anti-Inflammatory Properties 520
APOA-1Milano muteins, orally delivered via genetically modified rice, show anti-atherogenic and anti-inflammatory properties in vitro and in Apoe −/− atherosclerotic mice 485
Cardiac and neuronal HCN channelopathies 474
Two novel SCN5A loss-of-function mutations affect patients with severe arrhytmogenic syndromes 444
Simultaneous overexpression of human E5NT and ENTPD1 protects porcine endothelial cells against H2O2-induced oxidative stress and cytotoxicity in vitro 435
Effect of the ketogenic diet in excitable tissues 429
Modulation of the intrinsic neuronal excitability by multifunctional liposomes tailored for treatment of Alzheimer’s disease 413
Evaluation of gold nanoparticles biocompatibility: a multiparametric study on cultured endothelial cells and macrophages 404
Simultaneous overexpression of functional human HO-1, E5NT and ENTPD1 protects murine fibroblasts against TNF-α-induced injury in vitro 404
HCN ion channels and accessory proteins in epilepsy: genetic analysis of a large cohort of patients and review of the literature 393
Binary biocompatible CNCs-Gelatine hydrogel as 3D scaffolds suitable for cell culture adhesion and growth 380
Hypoxia-induced modifications in plasma membranes and lipid microdomains in A549 cells and primary human alveolar cells 378
A novel KCNJ2 mutation identified in an autistic proband affects the single channel properties of Kir2.1 374
Respiratory Mechanics and Fluid Dynamics After Lung Resection Surgery 369
Progressive epileptic encephalopathy associated with a novel HCN2 mutation 359
Gabapentin treatment in a patient with KCNQ2 developmental epileptic encephalopathy 359
Tissue specificity of mitochondrial adaptations in rats after 4 weeks of normobaric hypoxia 357
Brugada syndrome genetics is associated with phenotype severity 352
Glutamate transporters in platelets: EAAT1 decrease in aging and in Alzheimer's disease 342
Iron oxide nanoparticles surface coating and cell uptake affect biocompatibility and inflammatory responses of endothelial cells and macrophages 331
Role of the Air-Blood Barrier Phenotype in Lung Oxygen Uptake and Control of Extravascular Water 331
Interstitial pressure and lung oedema in chronic hypoxia 324
SCN4A mutation as modifying factor of Myotonic Dystrophy Type 2 phenotype 322
Hepcidin regulation in a mouse model of acute hypoxia 322
Do the functional properties of HCN1 mutants correlate with the clinical features in epileptic patients? 313
Cardiopulmonary Consequences of Post Thoracic Surgery Pulmonary Hypertension: Cause or Consequence of Lung Edema? 311
How ketogenic diet may be beneficial in controlling neuronal excitability? 304
From morphological heterogeneity at alveolar level to the overall mechanical lung behavior: an in vivo microscopic imaging study 299
SCN4A as modifier gene in patients with myotonic dystrophy type 2 297
Effect of nanoparticles binding ß-amyloid peptide on nitric oxide production by cultured endothelial cells and macrophages 296
Innovative therapies and nanomedicine applications for the treatment of alzheimer’s disease: A state-of-the-art (2017–2020) 295
Changes in the mechanical properties of the respiratory system during the development of interstitial lung edema 294
Oxygen-loaded nanodroplets effectively abrogate hypoxia dysregulating effects on secretion of MMP-9 and TIMP-1 by human monocytes 286
Pharmacological and Biochemical Characterization of TLQP-21 Activation of a Binding Site on CHO Cells 282
JMV5656, a novel derivative of TLQP-21, triggers the activation of a calcium-dependent potassium outward current in microglial cells 278
Novel SCN5A p.Val1667Asp Missense Variant Segregation and Characterization in a Family with Severe Brugada Syndrome and Multiple Sudden Deaths 278
The effect of nanoparticle uptake on cellular behavior: disrupting or enabling functions? 277
Accumulative Difference Image Protocol for Particle Tracking in Fluorescence Microscopy Tested in Mouse Lymphonodes 276
mRNA expression profile of selected oxygen sensing genes in the lung during recovery from chronic hypoxia 276
Study of the effects of nanoliposomes engineered for the treatment of Alzheimer's disease on the electrical activity of cortical neurons 274
GSTM3 variant is a novel genetic modifier in Brugada syndrome, a disease with risk of sudden cardiac death 273
Gold Branched Nanoparticles for Cellular Treatments 271
Dietary nanoparticles interact with gluten peptides and alter the intestinal homeostasis increasing the risk of celiac disease 271
A biophysical model of intracellular distribution and perinuclear accumulation of particulate matter 267
A novel de novo HCN2 loss-of-function variant causing developmental and epileptic encephalopathy treated with a ketogenic diet 264
Cardiac voltage-gated sodium channel Nav1.5 is regulated by Nedd4-2 mediated ubiquitination 262
Automated Patch-Clamp and Induced Pluripotent Stem Cell-Derived Cardiomyocytes: A Synergistic Approach in the Study of Brugada Syndrome 259
HCN1 novel mutations in familiar generalized epilepsy 258
Dynamic Investigation of Interaction of Biocompatible Iron Oxide Nanoparticles with Epithelial Cells for Biomedical Applications 256
The expression of the rare caveolin-3 variant T78M alters cardiac ion channels function and membrane excitability 256
Acetylation mediates Cx43 reduction caused by electrical stimulation 252
Identification and functional characterisation of a new KCNJ2 mutation 251
Experimental model to evaluate the effect of hydrothorax and lobar resection on lung compliance 250
An outlook on the potential of Si nanocrystals as luminescent probes for bioimaging 247
2H,3H-decafluoropentane-based nanodroplets: New perspectives for oxygen delivery to hypoxic cutaneous tissues 247
A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene 241
Nav1.5 E1053K mutation causing Brugada syndrome blocks binding to ankyrin-G and expression of Nav1.5 on the surface of cardiomyocytes 241
Alveolar mechanics studied by in vivo microscopy imaging through intact pleural space 238
HCN1 mutation spectrum: From neonatal epileptic encephalopathy to benign generalized epilepsy and beyond 237
Computer simulation of wild-type and mutant human cardiac Na+ current 235
Rational design of a mutation to investigate the role of the brain protein TRIP8b in limiting the cAMP response of HCN channels in neurons 232
A novel KCNC1 gain-of-function variant causing developmental and epileptic encephalopathy: "Precision medicine" approach with fluoxetine 231
Lipid-based nanoparticles (NPs) with high binding affinity for amyloid-beta1-42 peptide modulate the barrier properties of a monolayer of endothelial cells 231
Remodelling of Membrane Rafts Expression in Lung Cells as an Early Sign of Mechanotransduction-Signalling in Pulmonary Edema 227
T-Type Calcium Channels: A Mixed Blessing 227
Genetics of Long QT, Brugada, and Other Channelopathies 224
Functional Characterization of Two Variants at the Intron 6-Exon 7 Boundary of the KCNQ2 Potassium Channel Gene Causing Distinct Epileptic Phenotypes 223
Alterations of the Sialylation Machinery in Brugada Syndrome 221
Dextran-shelled oxygen-loaded nanodroplets reestablish a normoxia-like pro-angiogenic phenotype and behavior in hypoxic human dermal microvascular endothelium 219
Invitro- Invivo fluctuation spectroscopies 215
Cellular uptake of coumarin-6 as a model drug loaded in solid lipid nanoparticles 214
‘In Vitro’, ‘In Vivo’ and ‘In Silico’ Investigation of the Anticancer Effectiveness of Oxygen-Loaded Chitosan-Shelled Nanodroplets as Potential Drug Vector 214
The effect of exogenous surfactant on alveolar interdependence 214
BS-499656-002 Lethal Autoimmune Channelopathies: Nav1.5 Autoantibodies And Their Role In Sudden Cardiac Death 210
Unravelling Novel SCN5A Mutations Linked to Brugada Syndrome: Functional, Structural, and Genetic Insights 209
Chitosan-shelled oxygen-loaded nanodroplets abrogate hypoxia dysregulation of human keratinocyte gelatinases and inhibitors: New insights for chronic wound healing 208
Cardiac histological substrate in patients with clinical phenotype of Brugada syndrome 207
Ion Channel as Target for Drugs 207
A novel de novo HCN1 loss-of-function mutation in genetic generalized epilepsy causing increased neuronal excitability 206
Regional Differences in the protein patterns related to lung remodeling and oxygen sensing 201
NaV1.5 autoantibodies in Brugada syndrome: pathogenetic implications 199
Giovanni Alfonso Borelli, Giorgio Baglivi, and the origin of the heartbeat in the seventeenth century 197
Silica encapsulation of luminescent silicon nanoparticles: Stable and biocompatible nanohybrids 190
Mechanistic considerations on the development of lung edema: Vascular, perivascular and molecular aspects from early stage to tissue and vascular remodeling stage 182
Nanoparticles modulate the stability of the nuclear structure interfering in the mechanical connection between plasma membrane and nucleus 179
Ion channels in the heart 178
Cellular interaction with Si- and Iron-based nanoparticles for bio-imaging. A study of biocompatibility (Conference Paper ) 176
Cardiac sodium channel diseases 175
Fisiologia Medica - Terza Edizione 175
Bio-medical and sensor application of silicon nanoparticles 172
Novel arrhythmogenic mechanism revealed by a long-QT syndrome mutation in the cardiac Na(+) channel 170
Vander Fisiologia 168
SCN4A as modifier gene in myotonic dystrophy type 2 (DM2) patients with early and severe myotonia 168
In silico assessment of Y1795C and Y1795H SCN5A mutations: implication for inherited arrhythmogenic syndromes 160
Comparative expression of two oxygen-dependent transcription factors (O2TF) in lungs, heart and skeletal muscles in a rat model of chronic hypoxia (CH) 159
Markovian model for wild-type and mutant (Y1795C and Y1795H) human cardiac Na/sup +/ channel 156
A rabbit model of uremia-induced cardiomyopathy 152
Advances in the preparation of novel functionalized nanoparticles for bioimaging 146
Modulation of cardiac sodium channel gating by protein kinase A can be altered by disease-linked mutation 145
Totale 27.270
Categoria #
all - tutte 86.490
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 86.490


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021424 0 0 0 0 0 0 0 0 0 0 168 256
2021/20221.589 143 180 164 153 72 120 95 78 63 112 123 286
2022/20232.945 321 865 342 302 208 431 24 133 191 25 55 48
2023/20241.833 56 64 84 127 232 473 337 52 137 48 27 196
2024/20254.214 225 424 168 284 385 245 228 202 444 611 315 683
2025/20269.336 1.097 502 928 1.223 1.288 556 1.500 462 910 746 124 0
Totale 28.574